PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs
By Holly Campbell | March 3, 2020
Yesterday, PhRMA submitted comments on the Department of Health & Human Services’ (HHS) 2021 Notice of Benefit and Payment Parameters proposed rule. The proposed rule would hurt patients’ ability...
Read More
Addressing barriers that inhibit value-based contracts
By Katie Koziara | February 21, 2020
With 56 new medicines approved by the U.S. Food and Drug Administration (FDA) in 2019 and over 8,000 medicines in development around the globe, innovative medicines are transforming the way we...
Read More
New NHE data: Medicine prices declined, and hospitals were biggest driver of health care spending in 2018
By Holly Campbell | December 6, 2019
According to new data from the National Health Expenditures (NHE), retail medicine prices declined by 1% and retail medicine spending grew just 2.5% in 2018. To put that in context, hospital...
Read More
Guest post: Sharing discounts and rebates is the right thing to do
By Guest Contributor | October 21, 2019
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Survey shows out-of-pocket costs top health care concern for voters
By Holly Campbell | October 2, 2019
A recent national survey of 800 registered voters conducted by Public Opinion Strategies shows that health insurance premiums, deductibles and copays are the top health care concerns for...
Read More
Four reasons why the radical Pelosi Plan is the wrong approach
By Tom Wilbur | September 24, 2019
Speaker of the House Nancy Pelosi recently unveiled a radical plan that would restrict and fundamentally change how patients access medicines in the United States. It would threaten our country’s...
Read More
Hospitals make 9 times more than physicians’ offices on provider-administered medicines
By Katie Koziara | September 10, 2019
A new study, conducted by the Partnership for Health Analytic Research (PHAR), found that hospitals retained 91% of the total profit on physician-administered medicines in the commercial market...
Read More
Three things to know about the Part D GAO report
By Nicole Longo | August 16, 2019
The Government Accountability Office (GAO) recently released a new report looking at Medicare Part D and the role of Pharmacy Benefit Managers (PBMs) in the program. While the report provides a...
Read More
Four states adopt first-in-the-nation laws to protect patients from surprise insurer practices
By Nick McGee | July 15, 2019
West Virginia, Virginia, Arizona and Illinois recently became the first states in America to adopt patient-centered legislation to bring relief and more predictability to patients facing high...
Read More
The Department of Health and Human Services recently proposed a rule that would encourage using discounts negotiated between biopharmaceutical manufacturers and Part D plans to reduce patients’...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
